Emphagliflozin Tablets is a medication used in the treatment of type 2 diabetes mellitus. This works by inhibiting SGLT2, a protein responsible for the reabsorption of glucose in the kidneys. It belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. By blocking the reabsorption of glucose, empagliflozin helps to lower blood sugar levels by promoting the excretion of excess glucose through the urine. The dosage may vary depending on factors such as the individual's blood sugar levels, kidney function, and response to treatment. Emphagliflozin Tablets are typically taken orally, usually once daily, with or without food.